Literature DB >> 8900850

Autoimmune hemolytic anemia in multicentric Castleman's disease.

N L Liberato1, P Bollati, F Chiofalo, M Filipponi, M Poli.   

Abstract

We report on a patient affected by multicentric Castleman's disease who developed an acute immunohemolytic anemia due to warm antibody. The clinical course was characterized by refractoriness to the steroidal treatment and by a dramatic improvement of the hematological and objective picture following combination chemotherapy (CHOP regimen). The possible existence of a link between the lymphoproliferative syndrome and the immunological derangement is also discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900850

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  2 in total

Review 1.  Treatment of Castleman's disease.

Authors:  Angela Dispenzieri; Morie A Gertz
Journal:  Curr Treat Options Oncol       Date:  2005-05

2.  Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab.

Authors:  Sakiko Tabata; Tomoaki Higuchi; Seishiro Tatsukawa; Kazuyuki Narimatsu; Hiroaki Takeo; Susumu Matsukuma; Toshimitsu Ito
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.